Background The method of generating bioengineered skin constructs was pioneered several decades ago; nowadays these constructs are used regularly for the treatment of severe burns and nonhealing wounds. Commonly, these constructs are comprised of skin fibroblasts within a collagen scaffold, forming the skin dermis, and stratified keratinocytes overlying this, forming the skin epidermis. In the past decade there has been a surge of interest in bioengineered skins, with researchers seeking alternative cell sources, or scaffolds, from which constructs can be established, and for more biomimetic equivalents with skin appendages. Objectives To evaluate whether human hair follicle dermal cells can act as an alternative cell source for engineering the dermal component of engineered skin constructs. Methods We established in vitro skin constructs by incorporating into the collagenous dermal compartment: (i) primary interfollicular dermal fibroblasts, (ii) hair follicle dermal papilla cells or (iii) hair follicle dermal sheath cells. In vivo skins were established by mixing dermal cells and keratinocytes in chambers on top of immunologically compromised mice. Results All fibroblast subtypes were capable of supporting growth of overlying epithelial cells, both in vitro and in vivo. However, we found hair follicle dermal sheath cells to be superior to fibroblasts in their capacity to influence the establishment of a basal lamina. Conclusions Human hair follicle dermal cells can be readily interchanged with interfollicular fibroblasts and used as an alternative cell source for establishing the dermal component of engineered skin both in vitro and in vivo.
• As we and others have previously demonstrated the capacity of the same cells to induce new hair follicles, once the controls for modulating this duality of function have been established, it will be possible to engineer multiple components of a complex skin graft from the hair follicle dermis.Linked Comment: Jimenez. Br J Dermatol 2017; 176:1124-1125
Human skin is essentially comprised of two layers, an outer layer of ectoderm (multilayered epidermis) and an inner layer of mesenchyme (dermis). However, this integument is actually strikingly complex, being both richly innervated and vascularized, in addition to housing a complex immune system. It is also populated with hair follicles, as well as sebaceous, eccrine and apocrine glands, all of which arise from skin cells during development. Indeed, the skin has a range of functions additional to its primary role, which is that of a covering, or barrier. 1 It is the outer layer of the epidermis, the stratum corneum that provides this barrier function. This barrier not only acts as an immune defence to external pathogens but also maintains homeostasis of water and electrolytes within the body.
When the skin barrier function is compromised, after a wound or a burn, there are four consecutive but overlapping phases to wound repair: haemostasis, inflammation, proliferation and remodelling, all modulated by synergistic interactions between the dermis and epidermis. However, there are many instances in which wounds do not heal after injury, for example in the case of diabetic or chronic venous nonhealing ulcers. 2 Often this is as a result of one of the four stages of the healing process going awry. 3 These nonhealing wounds account for 2-4% of the healthcare budget in industrialized counties, with 1% of the population affected by such a wound at any time 4 and, as such, development of effective treatments is a major unmet medical need. The current gold standard treatment for a full-thickness wound such as a burn is a splitthickness autograft, harvested from a healthy, uninjured donor site on the patient. 5 However, many people with diabetic ulcers or other chronic wounds have underlying healing defects, and so autografts are not a suitable option. Moreover, there is a small subset of patients with congenital diseases that cause aberrant wound healing or blistering of the skin where again autografts are not a viable treatment option. 6 Grafting of bioengineered skin substitutes is currently an alternative treatment when autografts are not optimal. Over the last three decades the development of bioengineered skin substitutes has rapidly advanced, and using bioengineered skin to treat chronic wounds is now a reality. 7 Nevertheless, progress is still limited as no bioengineered skin can completely replicate the anatomy and physiology of an autograft. 8 In the 1970s, Rheinwald and Green developed a method to isolate and culture keratinocytes from the epidermis, 9 and this initial discovery promoted the development of skin substitutes such as EpiCel â (Genzyme Biosurgery, Cambridge, MA, U.S.A.) that provide an epidermal covering to a wound, acting as a temporary barrier replacement while promoting skin repair. 10 Factors present within the dermal component of the wound bed are crucial for recovery from fullthickness wounds, and commercial products such as Transcyte â (Shire plc, Dublin, Ireland), or Dermagraft â (Organogenesis Inc., Canton, MA, U.S.A.) have been developed that replace the dermis, providing essential growth factors and extracellular matrix to the wound bed. 8 There are limited bioengineered skin products that replace both the epidermal and dermal layers of the skin, although Apligraf â (Organogenesis Inc.) is one such US Food and Drug Administration-approved product; it is composed of neonate-derived fibroblasts cultured in a bovine collagen matrix, over which neonate-derived keratinocytes are seeded to produce a differentiated epidermis.
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There are now detailed protocols on composite skin establishment, 12, 13 and an expanding network of researchers are able to establish skin models within their laboratories. Additionally, efforts have focused on replacing the animalderived dermal matrix 14 or incorporating vascular networks into the dermal tissue to promote anastomosis, which would improve survival chances of the grafted tissue. 15, 16 Several epidermal and dermal populations can be isolated from the skin for use in skin regeneration. 17 However, in an effort to improve on the current bioengineered skin models, other researchers have sought to identify alternative tissue sources, for isolation of stem cells and generation of autologous skin substitutes. These include mesenchymal stem cells, 18 adipose cells 16, 19 and amniotic mesenchyme. 20 Another strategy has been to refine the subpopulation of skin fibroblasts being used, for example by focusing on those derived from the upper papillary layer of the dermis 21 or by using fibroblasts derived from human embryonic stem cells. 22 An alternative fibroblast cell source for use in skin constructs is hair follicle dermal cells, which are specialized fibroblasts. There are two populations of fibroblasts in the follicle, the dermal papilla and dermal sheath. Arising from the dermal condensate, papilla and sheath are derived from the same intermediate progenitors as papillary fibroblasts. 23 When isolated from the follicle and expanded by growth in culture, hair follicle dermal cells display multipotency and plasticity, and can differentiate down several mesenchymal lineages. 24 Moreover, in the presence of transforming growth factor beta 1 (which is expressed at high levels in wounded skin), rat dermal papilla cells transform and become more fibroblastlike. 25, 26 We have previously hypothesized that hair follicle dermal cells have an alternative function to their role within the hair follicle (namely, to promote hair growth), and can also act in a wound-healing capacity in the skin. 27 Additionally, the presence of hair follicles within skin has long been theorized to promote healing, as rodent skin heals faster after injury when follicles are in an active growth phase rather than their resting phase. 28, 29 Observations on recovery times after full-thickness wounds in hair-bearing mammals indicate that animals with higher hair densities heal faster and with less scar formation, while grafting of hair follicles into chronic leg ulcers has been shown to promote wound closure. 30 In these clinical observations the hair follicle disappears while promoting wound closure, suggesting that the cells are incorporated into the wound. 31 In addition to providing a source of cells for re-epithelialization, it is likely that the hair follicle also promotes dermal remodelling, aiding wound closure. 32 This remodelling may be in the form of matrix deposition, or perhaps the follicle may promote neovascularization. After all, vascular endothelial growth factor (VEGF) is an angiogenic factor expressed at highest levels within dermal cells of the follicle, 33 while in vitro dermal papilla cells promote significantly more tubulogenesis of human microvascular endothelial cells compared with nonfollicular fibroblasts. 34 We recently demonstrated that human hair follicle dermal cells act as a superior support for human keratinocytes in monolayer cultures, compared with human fibroblasts or irradiated 3T3 cells. 35 Additionally, hair follicle dermal papilla cells incorporated into a dermal matrix are capable of promoting contraction in skin wounds in nude mice. 36 We hypothesize that incorporation of hair follicle dermal cells into skin constructs used for wound covering will result in an improved bioengineered skin, as the dermal cells will act in a supporting role for the overlying keratinocytes in addition to promoting integration and vascularization at the wound site. Previously, hair follicle outer root sheath (epithelial) or bulge stem cells have been incorporated into skin constructs, [37] [38] [39] and even form the basis of bioengineered epithelial sheets that have been used for clinical application. 40 However, hair follicle dermal cells are an untapped source of cells for use in living bioengineered skins and their use is potentially a stepping stone to establishing hair follicles within bioengineered skin. 41 Indeed, recent studies have shown that human dermal papilla cells are capable of inducing hair follicles in skin constructs. 42 Uniquely, hair follicle dermal cells possess immunosuppressive properties, protecting them from rejection after transplantation. 43 This property alone confers an active benefit over other bioengineered skins as it opens up the possibility of utilizing hair dermal cells for allogenic transplants with reduced concern of rejection. In this manuscript we investigate the first but fundamental steps in this approach, specifically: (i) whether human hair follicle dermal cells support growth of overlying epithelial cells in a three-dimensional skin model; (ii) how the capacity of human hair follicle dermal cells to support epidermal keratinocytes compares with that of interfollicular dermal fibroblasts; and (iii) whether human hair follicle dermal cells retain any follicle-specific characteristics such as the ability to induce follicular structures.
Materials and methods

Establishment of cell cultures
After receiving ethical approval and institutional review board exemption from Columbia University Medical Center, occipital scalp skin samples were obtained as discarded tissue. To isolate hair follicle cells, follicle end bulbs were transected, then inverted using 27G needles to enable microdissection of the dermal papilla and dermal sheath. 44 with 10 mL L À1 penicillin, streptomycin and amphotericin B (Fungizone; Invitrogen). They were allowed to settle in an incubator for 10 days, after which time the papilla or sheath structures had collapsed and cells had started to migrate out from them in an explant, starburst formation. The medium was also changed to 10% FBS in DMEM with 10 mL L À1 penicillin and streptomycin. Once 35-mm dishes were filled with cells, they were passaged using 0Á5% trypsin/ethylenediaminetetraacetic acid, and split at a 1 : 2 ratio. To isolate fibroblasts, skin biopsies were transected using a scalpel blade just beneath the epidermis, roughly separating the papillary and reticular dermis. Hair fibres were removed and the papillary dermis was then chopped up into fine pieces using small scissors. These small pieces were adhered to a 35-mm dish, and once attached, 20% FBS in DMEM with 10 mL L À1 penicillin, streptomycin and amphotericin B were added to the culture. Fibroblast cells migrated out of these explants, which were then passaged in a similar manner to the papilla cells and sheath cells. Fibroblasts, dermal sheath and dermal papilla cell lines that were matched (from the same skin donor) were then used for comparison against each other in later experiments. Cells from three different donors were used in these experiments. Keratinocytes were subsequently isolated from discarded neonatal skin. Under the Code of Federal Regulations Title 45: Public Welfare Part 46, neonatal skin samples were designated as nonhuman subject research and we therefore received an institutional review board exemption at Columbia University to use these materials. Briefly, skin was placed in 2Á4 mg mL À1 dispase overnight at 4°C, after which time the epidermis and dermis were separated using forceps. The epidermis was roughly minced, then placed into TrypLE â (Invitrogen) for 30 min at 37°C, after which time the reaction was stopped, and cells were passed through a 70-lm cell strainer. Isolated keratinocytes were grown in Epilife â (Invitrogen).
Generation of in vitro bioengineered skin
To establish skin constructs we followed the methods described in detail by Carlson et al., 12 but instead of using bovine collagen (Organogenesis Inc.), we used 3Á7 mg mL À1 rat-tail collagen (BD Biosciences, San Jose, CA, U.S.A.) in establishing medium. Constructs were established in parallel from fibroblasts, dermal papilla cells and dermal sheath cells from matched donors. After establishing dermal scaffolds, constructs were left to contract for 7 days prior to the addition of keratinocytes. Keratinocytes used were at passage one or two, grown in serumfree medium. After adding keratinocytes, constructs were kept for 4 days in 12 mL epidermalization I medium and 2 days in epidermalization II medium, prior to feeding with cornification medium.
12 Only 7 mL cornification medium was used, enabling exposure of the construct surface to the air-liquid interface. Constructs were maintained in cornification medium for a further 11 days, meaning the total time between establishing the dermal layer and ending the experiment was 24 days.
Generation of skin in vivo
Dermal fibroblasts, dermal papilla cells, dermal sheath cells or keratinocytes were trypsinized, counted and resuspended in phosphate-buffered saline (PBS). Ten million keratinocytes were then combined with either 10 million fibroblasts or 10 million dermal papilla cells. Cell mixtures were centrifuged and resuspended in 100 lL PBS. This resultant cell slurry comprising epidermal and dermal cells was then pipetted into a hole located on the top of a sterile silicone chamber (Renner GmbH, Dannstadt, Germany), which had previously been inserted under the dorsal skin of a severe combined immunodeficiency mouse. This work was performed after approval from the Institutional Animal Care and Use Committee at Columbia University. After one week the silicone chamber was removed and cells were left for a further 2 weeks. Three weeks after cell grafting, skin structure could be observed. This was harvested for subsequent analysis.
Histological and immunofluorescence analysis of bioengineered skin
Skin constructs were placed in 2-mol L À1 sucrose overnight, prior to embedding in optimal cutting temperature compound and freezing; 7-lm sections were then cut on a cryostat and mounted onto positively charged glass slides. Sections were air dried at room temperature for 1 h then fixed with either 4% paraformaldehyde in PBS for 10 min at room temperature or with chilled acetone/methanol 1 : 1 at À20°C for 7 min. Fixative was removed by washing slides in PBS three times, with 3-min intervals at room temperature. Two-percent fishskin gelatin (Sigma-Aldrich) in PBS was applied to sections for 1 h, to block nonspecific binding. Block was removed by tapping the edge of the slide gently, and primary antibodies (Table 1) were then applied to slides prior to their being left overnight at 4°C. The next day, primary antibodies were removed by washing slides three times, with 3-min intervals in PBS. Secondary antibodies (goat antirabbit 488/594 or goat antimouse 488/594; Thermo Fisher Scientific, Waltham, MA, U.S.A.) were diluted 1 : 800, and then applied to slides and left for 1 h at room temperature, shielded from light. Secondary antibodies were washed off slides using three washes of PBS, and coverslips were mounted using VECTASHIELD (Vector Laboratories Inc., Burlingame, CA, U.S.A.) containing 4 0 ,6-diamidino-2-phenylindole. Slides were visualized and images taken on an LSM Exciter confocal laser scanning microscope (Carl Zeiss, Oberkochen, Germany). For histological analysis, sections were stained using haematoxylin and eosin, prior to mounting coverslips with DPX (distyrene, a plasticizer, and xylene).
Transmission electron microscopy analysis
Skin constructs were placed in freshly made Karnovsky fixative, comprising 2% paraformaldehyde and 2Á5% glutaraldehyde in 0Á1 mol L À1 phosphate buffer. 45 Specimens were then postfixed in 1% OsO 4 (Agar Scientific, Stansted, U.K.) buffered in 0Á2 mol L À1 sodium phosphate buffer, pH 7Á4.
After postfixing, they were dehydrated through a series of ascending grades of ethanol (70%, 95%) with three changes, each lasting 15 min, followed by immersion in absolute ethanol, for three 30-min intervals. Following this, the samples were immersed in an intermediate solution consisting of a 50 : 50 mix of 100% alcohol and propylene oxide. After three changes, 10 min apart, they were moved to propylene oxide, again with three changes, and 10-min intervals. They were then placed in a fresh 50 : 50 Araldite resin/propylene oxide mix and left overnight for the resin to infiltrate and the propylene oxide to evaporate. The resin was composed of (in 46Á2 g) 23 g Araldite CY 212, 22 g dodecenylsuccinic anhydride and 1Á2 g benzyldimethylamine (Agar Scientific). The next day, specimens were placed in fresh resin for 30 min, then into rubber moulds with fresh Araldite, which was subsequently left to polymerize for 48 h at 60°C. Ultrathin sections were cut using a diamond knife on a Reichert Ultracut S ultramicrotome (Leica, Wetzlar, Germany) and transferred to formvar-coated grids. Sections were then stained with 1% uranyl acetate in 70% ethanol, washed in water, then stained with Reynolds lead citrate for visualizing. Ultrathins were imaged on a Hitachi H7600 transmission electron microscope (Hitachi, Tokyo, Japan).
Results
Differentiation, stratification and proliferation in bioengineered skins
After establishment of in vitro skin constructs, the morphology of the newly formed epidermis was assessed on haematoxylin and eosin-stained sections. At the 24-day time point when skin constructs were embedded, they had been in cornification medium, raised to the air-liquid interface and undergoing a program of differentiation for 11 days. On each of the three dermal substrates, epidermal proliferation and differentiation had occurred to form a continuous epidermal covering. On top of all three dermal cell types, epidermal cells perpendicular to the dermal-epidermal junction formed a clear basal layer (Fig. 1a-c) . Above this, a noticeable change in cell orientation was visible, resulting in more horizontally aligned cells, forming the stratum spinosum. Above the spinous layer, the stratum granulosum layer was characterized by cells containing keratohyalin granules. The stratum corneum was also present in all skin constructs as a thickened, non-nucleated layer. There were no obvious differences in the equivalents containing hair follicle dermal cells when compared with a fibroblast support layer, indicating that hair follicle dermal cells are capable of supporting growth and differentiation of overlying epidermal cells, in a manner similar to that of regular interfollicular fibroblasts.
Immunofluorescence was then used to assess whether the equivalents expressed specific differentiation markers, present within the various layers of normal epidermis. The epidermis has a changing profile of keratins, which provide stability to the epidermal cells, but also enable discrimination of differentiated layers. Keratin (K)5 and K1 were investigated, as the former marks basal epidermis while the latter demarcates keratins present within the suprabasal epidermis, not including the stratum corneum. Loricrin (LOR) is a major component of the cornified cell envelope barrier and is present within the terminally differentiated stratum corneum. While K5 was exclusive to the basal layer in control skin, within skin equivalents supported by all three dermal cell types K5 was seen both in the basal layer and at weaker levels in the suprabasal keratinocytes (Fig. 1d-g ). Comparatively, in both control skin and all skin constructs, K1 was exclusively within the suprabasal keratinocytes and was absent from the basal layer (Fig. 1h-k) . Moreover, LOR expression was restricted to the stratum corneum of control skin and bioengineered skin constructs incorporating either fibroblasts or hair follicle dermal cells, indicating that a normal program of differentiation and stratification was occurring in all cases (Fig. 1l-o) .
While the presence of cytokines within skin constructs has been shown to stimulate wound repair after skin construct grafting, 46 another important factor is the viability of the graft. When the presence of the proliferation marker Ki-67 was assessed, a low number of proliferating basal keratinocytes was observed in the control skin, and similar labelling was seen within all three skin construct types in addition to the occasional proliferating dermal cell (Fig. 1p-s) . Desmosomes are present throughout the basal and suprabasal epidermis, while corneodesmosomes are in the stratum corneum. Desmosomes enable connection of adjacent cells within the epidermis and provide integrity, preventing shearing of the skin. The expression of both desmoglein (Dsg)3 and desmoplakin (Dsp) was investigated to evaluate desmosomal protein synthesis within our bioengineered skins. In control skin, Dsg3 was expressed within both the basal and suprabasal layers, with strongest expression observed in the stratum basale and stratum spinosum (Fig. 2a) . Dsp was expressed in all basal and suprabasal cells, although strongest expression was observed within the stratum spinosum and stratum granulosum. Within skin constructs, with dermal fibroblasts, papilla or sheath cells supporting the keratinocytes, Dsg3 was observed in both the basal and suprabasal layers of skin, with the strongest expression seen in the basal layer ( Fig. 2b-d) . Dsp was observed at low levels in the basal layer but increased in intensity within the stratum spinosum ( Fig. 2e-h ). Transmission electron microscopy showed that in constructs supported by all three cell types, numerous desmosomes were linking cells throughout the basal and suprabasal layers of the epidermis. (Fig. 2i-k) .
Basement membrane formation in bioengineered skins
Immunofluorescence was used to assess the expression of basement membrane components within the bioengineered skin constructs. This is predominantly comprised of extracellular matrix proteins, synthesized by the epidermal keratinocytes. However, dermal cells are important here, as they stimulate the epidermis to deposit a basal lamina. 47 While levels of type VII collagen (COL7) staining were relatively similar in the basement membrane of different bioengineered constructs (Fig. 3a-d) , type IV collagen (COL4) labelling was most intense in the basement membrane of constructs supported by dermal sheath cells from the hair follicle (Fig. 3e-h) . Quantification of membrane thickness by assessing COL4 expression revealed that dermal sheath-supported constructs had significantly thicker basement membranes compared with the fibroblast and dermal papilla constructs (Fig. 3i) .
The extent of basal lamina formation in skin constructs was then assessed using transmission electron microscopy. While some basal lamina could be detected in all three bioengineered skin constructs, within the fibroblast-supported specimens the basal lamina was patchy, and did not show continuity across the entire construct (Fig. 3j) . Moreover, the basal lamina, which has a clear three-layered structure in electron micrographs, was often missing its most basal layer of the three. Dermal papilla-supported constructs had a largely consistent, three-layered basal lamina; however, there were areas where it was not intact and resembled the basal lamina in the fibroblast-supported constructs (Fig. 3k) . In contrast, the basal lamina in hair follicle dermal sheath-supported constructs was thickened, rarely showing areas of breakage, indicating a consistent deposition across the entire construct (Fig. 3l) . In dermal sheath-supported constructs, anchoring fibril-like projections were observed from the constructs that made contact with the basal lamina ( Fig. S1 ; see Supporting Information). This was rarely observed within the constructs supported by either dermal fibroblasts or dermal papilla cells.
Dermal identity in bioengineered skins
An interesting facet of hair follicles is that the dermal sheath expresses alpha smooth muscle actin (aSMA), an actin isoform usually present in smooth muscle cells or myofibroblasts. 48 In healing wounds, the transient presence of aSMA expressing myofibroblasts enables wound contracture to occur. 49, 50 Using antibodies specific to aSMA, we analysed the expression in the dermis of our three different bioengineered skin constructs ( Fig. 4a-d) . In control skin that is unwounded, aSMA is usually only located around blood vessels and in hair follicle dermal sheath. However, in culture, aSMA switches on in dermal papilla cells, so it is expressed by both hair follicle fibroblast populations. 48 We did not observe aSMA within the dermis of constructs supported by fibroblasts; however, high expression levels were seen in constructs supported by both hair follicle dermal sheath and hair follicle dermal papilla cells. This indicates that hair follicle dermal cells maintain their cell identity in engineered skin constructs.
In addition to differences in expression, hair follicle dermal cells are distinct from interfollicular fibroblasts in a number of ways. In specific conditions, human dermal papilla cells have been shown to be capable of promoting hair follicle growth when combined with competent human epithelium or human epithelial cells. 42, 51 However, within our time frame in vitro we did not observe any induction of hair follicles or anomalous follicle-like structures.
Formation of de novo skin in vivo
In addition to analysing engineered skins assembled layer by layer in vitro, we also assessed whether all three fibroblast populations could support establishment and organization of human keratinocytes in vivo. When we introduced a slurry of keratinocytes together with either fibroblasts, dermal papilla cells or dermal sheath cells into chambers on the backs of mice, the cells quickly self-organized to form a skin structure. Histological analysis of these regions after 3 weeks showed that cells had reorganized with dermal cells on the inner surface and keratinocytes exposed to the external air interface ( Fig. S2a-c ; see Supporting Information). Further
Desmosomal junctions in skin constructs. Desmoglein (Dsg)3 expression in normal human skin (a) is observed within the basal and spinous layers of the epidermis. In skin constructs supported by (b) fibroblasts (DFI), (c) dermal papilla (DP) cells and (d) dermal sheath (DS) cells, Dsg3 expression is observed within the lower layers of the epidermis; however, the pattern is not as well defined as in control skin. (e) In control skin, desmoplakin (Dsp) expression is observed in the suprabasal layers of the epidermis, in a defined cell-border pattern. In epidermis supported by DFI (f), DP cells (g) and DS cells (h), expression is observed in the suprabasal layers of the construct. Using transmission electron microscopy to visualize DFI-supported constructs (i), in addition to those supported by DP (j) or DS (k) cells we observed several desmosomes present at the cell surface of keratinocytes, enabling cell-cell contact and adhesion. Scale bars = 10 lm.
analysis was only performed on comparisons of hair follicle dermal papilla and interfollicular fibroblasts. In epidermis supported by both fibroblasts and dermal papilla cells the keratinocytes had differentiated and formed stratified layers, creating a human skin on the back of a mouse ( Fig. S2d-f ; see Supporting Information). K1 was expressed in the suprabasal layers of skins supported with both fibroblasts and dermal papilla cells, while Dsg3 was clearly present within the basal and spinous layers ( Fig. S3a-d ; see Supporting Information). Basement membranes were also established, as indicated by the presence of COL7 and COL4 (Fig. S4a, b (e) In normal human skin, the basal lamina is composed of type IV collagen (COL4). Likewise, expression is observed in skin constructs with DFI support (f), and a DP cell (g) support. In constructs supported by DS cells (h), high levels of COL4 were observed. (i) Whisker box plot of COL4 thickness, showing DS constructs had significantly thicker membranes than DP and DFI skins. (j) Transmission electron microscopy of the basal lamina (between arrows) of DFI-supported constructs showed a thin lamella, often missing the most basal layer, and strewn with gaps. In constructs supported by DP cells (k), the lamina (between arrows) was thicker, but there were often areas where it failed to fully form. However, in skin constructs supported by DS cells (l), the basal lamina (between arrows) was nicely formed and showed its characteristic three-layered pattern. Moreover, the lamina was consistently visible across the entire construct. Scale bars = 1 lm. ***P < 0Á001. 
Discussion
In this study our principal goal was to determine if human hair follicle-derived dermal cells were capable of supporting the growth of epithelial cells in a three-dimensional construct to form a viable bioengineered skin. We have successfully demonstrated that both dermal papilla cells and dermal sheath cells can replace interfollicular fibroblasts in skin constructs and, in one specific feature, namely basement membrane formation, dermal sheath cells are superior to fibroblasts. This supports the idea that hair follicle dermal cells have a dual capacity in the skin. In addition to being integral to the hair follicle and driving hair follicle cycling, they are also capable of switching to support epidermal growth and renewal in a regenerative context. 52 In this regard they parallel to some extent the follicle epithelial outer root sheath progenitors, which can also display a dichotomy of activity within skin. Indeed, human hair follicle epithelial cells have already been used for skin replacement in a clinical context. 40 We also showed that follicle dermal cells are capable of constituting skin dermis as part of reconstituted skin dermis in vivo, but follicle dermal cells did not induce follicular structures either in vitro or in vivo.
One predominant requirement of the dermal portion of a bioengineered skin is to support the overlying epidermis and maintain the cells in a viable state. The dermis and epidermis have a synergistic relationship, perhaps explaining why bioengineered skins with only an epidermis are not long lived. The dermis provides structural support for the overlying keratinocytes, enabling production of key basement membrane components. Interestingly, one area where the hair follicle dermal cells appeared superior to interfollicular fibroblasts was in their capacity to influence the establishment and maintenance of a basal lamina. Dermal cells are capable of stimulating overlying keratinocytes to deposit a basal lamina. 53 In our skin constructs containing hair follicle dermal cells, in particular dermal sheath cells, we saw an increase in COL4 expression compared with fibroblast-supported constructs, coinciding with the formation of a robust and uniform basal lamina as shown by electron microscopy. This capacity to stimulate basal lamina formation is perhaps not surprising, given that in situ the dermal sheath contributes to and stimulates the formation of the substantial and complex basement membrane structure termed the glassy membrane, which separates dermal sheath from epithelium around the hair follicle. One key role of a bioengineered skin is to promote wound closure after grafting, by providing a moist wound environment that will stimulate skin repair and replacement. Skin constructs supported by hair follicle dermal cells had a wellstratified epidermis and cornified stratum corneum layer as indicated by LOR staining. This will enable the bioengineered skin to form a barrier to external influences, while also trapping in water and solutes to create an environment that will promote healing. Another key role of bioengineered skins is to produce cytokines that positively influence the healing process. Interestingly, VEGF is expressed at very high levels within hair follicle dermal cells, 33 allowing us to postulate that grafted skin constructs containing hair follicle dermal cells may in some way promote vascularization and therefore integration of the skin construct to enable faster wound healing. One interesting feature of our hair follicle-derived skin constructs was the presence of aSMA, a marker of myofibroblasts, within the dermis of skin constructs. This demonstrated that the hair follicle-derived cells, while assuming the role of dermal fibroblasts were, nevertheless, maintaining some folliclespecific characteristics. Hair follicle dermal sheath cells express aSMA in vivo, while both dermal papilla cells and dermal sheath cells express the marker in vitro. 48 There is a positive correlation with aSMA expression and the contractile activity of fibroblasts. 54 We therefore hypothesize that the presence of aSMA within grafted skin constructs would help to create an environment conducive to healing by promoting contracture of the wound.
We have previously shown in rodents that adult whisker follicle dermal cells can contribute to wounded skin dermis and form the dermis in a reconstructed skin model in vivo.
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Here we have demonstrated that likewise, human hair follicle dermal cells are capable of supporting overlying epidermal cells in a bioengineered skin. While several groups are exploring the possibility of incorporating alternative cell types into skin constructs, it is still essential that we investigate alternative cell types within the skin as a novel cell source for engineering skin.
Our findings reported in this manuscript support our previous observations that hair follicle dermal cells are superior to fibroblasts when used as a feeder layer to support keratinocytes in culture. 35 With the recent explosion of interest in de novo hair follicle formation, we have to postulate that incorporation of hair follicle dermal cells within skin constructs will be a stepping stone to enable growth of hairy bioengineered skins. Our bioengineered skins were maintained for 3-4 weeks in culture, and at no point did we observe de novo follicle formation within our constructs. Similarly, we did not observe any signs of hair follicle formation in our in vivo skins. Others have produced follicles in their skin constructs, 42, 56 raising the question of why this did not occur
here. This could be due to different methods; in other protocols in vitro skin constructs were established then grafted onto nude mice to ensure survival up to 15 weeks, while ours were only maintained for 3-4 weeks. 42 Alternatively, incorporating dermal papilla spheroids into the skin construct dermis can enable papilla inductivity, 56 while in our study we only used dispersed hair follicle dermal cells. Another possibility is that there are individual and/or site-specific differences between the hair follicle populations used in different studies. 42 Notwithstanding this, incorporation of hair follicles into constructs by exploiting the inherent properties of the dermal cells to induce new hair structures is a first step to recreating a functional skin; however, controlling follicle depth and directionality are other obstacles that lie ahead. 57 Current bioengineered human skins are devoid of organized hair follicles, and indeed other structures such as blood vessels and nerves that together make the skin a highly complex structure. Introduction of various skin-derived cell types into bioengineered constructs will no doubt over time enable the creation of bioengineered skins that more closely recreate or mimic the complexity of human skin.
